Ustekinumab Subcutaneous and Xultophy
Determining the interaction of Ustekinumab Subcutaneous and Xultophy and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab (Subcutaneous)
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Xultophy 100/3.6
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ustekinumab Subcutaneous-Xultophy 100/3.6
- Ustekinumab Subcutaneous-Xuriden
- Ustekinumab Subcutaneous-Xylocaine
- Ustekinumab Subcutaneous-Xylocaine (Cardiac)
- Ustekinumab Subcutaneous-Xylocaine (Lidocaine Injection Solution (Anesthetic))
- Ustekinumab Subcutaneous-Xylocaine (Lidocaine Oral Liquid and Solution)
- Xultophy-Ustekinumab Subcutaneous Injection
- Xultophy-Ustell
- Xultophy-UTA
- Xultophy-UTA Capsules
- Xultophy-UTAC tablets
- Xultophy-UTI Relief